-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2024.
- OnKure Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 3.34M shares, a 1.12% decline year-over-year.
- OnKure Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 30.7M shares, a 25.2% increase from 2022.
- OnKure Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 24.5M shares, a 35% increase from 2021.
- OnKure Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 18.1M shares, a 795% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)